ENDOMETRIAL HYPOPLASIA

This adverse event was reported 24 times

ENDOMETRIAL HYPOPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOLLITROPIN ALFA 1 0.0005
1 CHORIOGONADOTROPIN ALFA 1 0.0004
2 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
3 GOSERELIN 2 0.0001
4 ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE 1 0.0001
5 ACETAMINOPHEN, ASPIRIN, AND CAFFEINE 1 0.0000
6 PROGESTERONE 1 0.0000
7 LEVONORGESTREL 6 0.0000
8 IPRATROPIUM BROMIDE 1 0.0000
9 OLANZAPINE PAMOATE 1 0.0000
See all drugs enriched for association with ENDOMETRIAL HYPOPLASIA

ENDOMETRIAL HYPOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gonadotropin [EPC] 1 0.0005
1 Progesterone [EPC] 1 0.0000
2 Progestin [EPC] 6 0.0000
3 Copper-containing Intrauterine Device [EPC] 1 0.0000
4 Methylxanthine [EPC] 1 0.0000
5 Central Nervous System Stimulant [EPC] 1 0.0000
6 Estrogen [EPC] 2 0.0000
7 Aromatase Inhibitor [EPC] 1 0.0000
8 Vitamin D [EPC] 2 0.0000
9 Retinoid [EPC] 1 0.0000
See all drug classes enriched for association with ENDOMETRIAL HYPOPLASIA